NCT03300830View on ClinicalTrials.gov

Molecular Characterization of Viral-associated Tumors, Tumors Occurring in the Setting of HIV or Other Immune Disorders and Castleman Disease

RecruitingOBSERVATIONAL

Enrollment

280

Participants

Timeline

Start Date

December 20, 2017

Primary Completion Date

June 7, 2037

Study Completion Date

June 25, 2037

Conditions

Human Immunodeficiency VirusCastleman's DiseaseKaposi's SarcomaViral-Associated Cancer

Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors

lead

National Cancer Institute (NCI)

NIH